Core Viewpoint - The Ensign Group, Inc. has declared a quarterly cash dividend of $0.0650 per share, payable by April 30, 2026, to shareholders of record as of March 31, 2026 [1]. Company Overview - The Ensign Group, Inc. operates independent subsidiaries that provide a wide range of skilled nursing and senior living services, as well as physical, occupational, and speech therapies across 378 healthcare facilities in various states [3]. - The company has been consistently paying dividends since 2002, indicating a stable financial performance and commitment to returning value to shareholders [2].

Management also emphasized progress in how it transitions newly acquired facilities. Port said Ensign often takes on buildings that require “heavy lifting,” and that the company’s building-by-building approach has improved. He added that Ensign’s scale and leadership depth have enabled it to take on more buildings at a single time, while accelerating the historical trajectory of improvement during transitions. That, in turn, has increased confidence in maintaining growth pace and potentially entering new st ...

The Ensign Group (NasdaqGS:ENSG) FY Conference March 19, 2026 10:40 AM ET Company ParticipantsAdam Willits - PresidentBarry Port - CEOChad Keetch - Chief Investment OfficerLanie Mai - Chief Accounting OfficerMichael Wiederhorn - Managing DirectorMichael WiederhornGood morning. Welcome to Oppenheimer's 36th Annual Healthcare MedTech & Services Conference. I am Michael Wiederhorn, the healthcare analyst. It's our pleasure to introduce The Ensign Group. Today, we have the Chief Executive Officer, Barry Port, C ...

Core Insights - The Ensign Group, Inc. will participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026, to discuss its operations and growth strategy [1][2] Company Overview - The Ensign Group operates 378 healthcare facilities across 15 states, providing skilled nursing, senior living services, and various rehabilitative and healthcare services [3]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Ensign Group (ENSG) - Ensign Group currently holds a Momentum Style Score of A, indicating strong momentum potential [3] - The company has a Zacks Rank of 2 (Buy), suggesting favorable market performance [4] Performance Metrics - Over the past week, ENSG shares increased by 1.68%, while the Zacks Medical - Nursing Homes industry rose by 2.68% [6] - In a longer timeframe, ENSG's monthly price change is 24.76%, significantly outperforming the industry's 2% [6] - Over the past quarter, ENSG shares have risen by 20.34%, and over the last year, they have gained 65.83%, compared to the S&P 500's increases of 1.28% and 18.65%, respectively [7] Trading Volume - ENSG's average 20-day trading volume is 466,248 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, two earnings estimates for ENSG have been revised upwards, with the consensus estimate increasing from $7.05 to $7.48 [10] - For the next fiscal year, two estimates have also moved upwards, with no downward revisions [10] Conclusion - Given the strong performance metrics and positive earnings outlook, ENSG is positioned as a solid momentum pick with a Momentum Score of A and a Zacks Rank of 2 (Buy) [12]

Core Viewpoint - The Ensign Group (ENSG) demonstrates a strong capability in identifying and acquiring distressed assets, leveraging a decentralized leadership model to improve clinical and financial performance, and ultimately capitalizing on growth opportunities [1] Group 1 - The company has a consistent track record of acquiring distressed assets, which positions it well for future growth [1] - The decentralized leadership model employed by the company enhances both clinical and financial performance, allowing for more effective management and operational efficiency [1] - The focus on capitalizing on growth opportunities indicates a proactive approach to investment and asset management [1]

Core Insights - The Ensign Group, Inc. (ENSG) reported a fourth-quarter 2025 adjusted EPS of $1.82, exceeding the Zacks Consensus Estimate by 4%, with a year-over-year improvement of 19.5% [1][8] - Operating revenues increased by 20.2% year over year to $1.36 billion, although this figure fell short of the consensus estimate by 0.5% [1][8] - The strong earnings performance was driven by improved occupancy rates, higher patient days, and enhanced skilled service performance, despite being partially offset by increased expenses [1] Financial Performance - Adjusted net income for the quarter was $107.8 million, reflecting a 23.2% year-over-year increase [2] - Same-facilities occupancy rose by 240 basis points to 83.8%, while transitioning-facilities occupancy increased by 290 basis points year over year to 84.9% [2] - Total expenses grew by 19.9% year over year to $1.24 billion, primarily due to higher costs of services, rent, and general & administrative expenses, but were lower than the estimated $1.25 billion [2] Segment Performance - Skilled Services segment revenues reached $1.3 billion in Q4, a 20.2% year-over-year growth, although it missed estimates by 1.5% [3] - Segment income for Skilled Services increased to $169.3 million from $141 million a year ago [3] - Rental revenues surged by 37.2% year over year to $34.5 million, supported by buyouts, with segment income rising 38.3% year over year to $10.3 million [4] Financial Position - As of December 31, 2025, cash and cash equivalents stood at $503.9 million, up from $464.6 million at the end of 2024 [5] - Total assets increased to $5.5 billion from $4.7 billion at the end of 2024 [5] - Long-term debt, excluding current maturities, decreased to $137.5 million from $141.6 million as of December 31, 2024 [6] 2026 Outlook - Revenues for 2026 are projected to be between $5.77 billion and $5.84 billion, an increase from the 2025 level of $5.06 billion, which grew 18.7% year over year [7] - Adjusted EPS is expected to be in the range of $7.41 to $7.61 for 2026, higher than the 2025 level of $6.57, which grew 19.5% year over year [7] - The estimated weighted average common shares outstanding is around 60 million, with a tax rate expected at 25% [7]

Core Insights - The Ensign Group reported record financial results for fiscal 2025, with a GAAP diluted EPS of $5.84, an increase of 14.1%, and consolidated revenue of $5.1 billion, up 18.7% [6][15][17] - The company highlighted strong operational metrics, including same-store occupancy rates reaching all-time highs of 83.8% and transitioning occupancy at 84.9% [1][4] - Ensign's management emphasized the importance of clinical performance linked to staff retention, with a notable 33% reduction in director of nursing turnover over recent years [2][3] Financial Performance - For Q4, Ensign reported a GAAP diluted EPS of $1.61, up 18.4%, and consolidated revenue of $1.4 billion, an increase of 20.2% [17] - The company ended fiscal 2025 with $504 million in cash and a lease-adjusted net debt/EBITDA ratio of 1.77x, indicating strong financial health [6][17] - Fiscal 2026 guidance includes diluted EPS of $7.41 to $7.61 and revenue projections of $5.77 billion to $5.84 billion [19] Operational Highlights - The company added 17 new operations during the quarter, increasing its skilled nursing bed capacity by 1,371 across seven states [5][8] - Skilled days increased by 8.5% for same-store operations and 10% for transitioning operations compared to the prior year [9] - Ensign's same-store operations outperformed peers in quality measures, achieving a 24% advantage at the state level and a 33% advantage at the county level [3] Growth Strategy - Ensign's active acquisition pipeline is described as healthy but increasingly competitive, with over $1 billion available for future investments [5][6] - The company is focusing on organic growth potential, with occupancy levels still below those of mature operations, indicating room for expansion [7] - Management is pursuing strategic capital projects, including new construction and facility upgrades, to enhance service capacity [10][16] Clinical and Staffing Improvements - The company reported improvements in clinical outcomes, with same-store operations achieving five-star quality measure results that were 22% better nationally [3] - Staffing agency usage has decreased, and stable wage growth has contributed to improved staff retention, supporting care quality [2][20] - Specific facilities, such as South Bay Post Acute and Shoreline Health, demonstrated significant operational improvements and revenue growth through specialized care programs [13][14]

分组1 - Ensign Group (ENSG) reported quarterly earnings of $1.82 per share, exceeding the Zacks Consensus Estimate of $1.75 per share, and up from $1.49 per share a year ago [1] - The earnings surprise for this quarter was +4.00%, and the company has surpassed consensus EPS estimates in all four of the last quarters [2] - The company posted revenues of $1.36 billion for the quarter, which was below the Zacks Consensus Estimate by 0.53%, but an increase from $1.13 billion year-over-year [3] 分组2 - Ensign Group shares have declined approximately 0.3% since the beginning of the year, while the S&P 500 has gained 1.1% [4] - The current consensus EPS estimate for the upcoming quarter is $1.73 on revenues of $1.35 billion, and for the current fiscal year, it is $7.09 on revenues of $5.64 billion [8] - The Medical - Nursing Homes industry, to which Ensign Group belongs, is currently ranked in the top 12% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [9]

Financial Performance - GAAP diluted earnings per share for the year was $5.84, an increase of 14.1% over the prior year, and for the quarter was $1.61, an increase of 18.4% over the prior year quarter [2]. - Adjusted diluted earnings per share for the year was $6.57, an increase of 19.5% over the prior year, and for the quarter was $1.82, an increase of 22.1% over the prior year quarter [2]. - Consolidated revenue for the year was $5.06 billion, an increase of 18.7% over the prior year, and for the quarter was $1.36 billion, an increase of 20.2% over the prior year quarter [2]. - Total skilled services revenue was $4.84 billion for the year, an increase of 18.7% over the prior year, and $1.30 billion for the quarter, an increase of 20.2% over the prior year quarter [2]. - Total revenue for the year ended December 31, 2025, was $5,057,841, an increase of 18.7% from $4,260,485 in 2024 [19]. - Service revenue for the three months ended December 31, 2025, reached $1,353,885, up 20.2% from $1,126,374 in the same period of 2024 [19]. - Net income attributable to The Ensign Group, Inc. for the year ended December 31, 2025, was $343,971, representing a 15.4% increase from $297,973 in 2024 [24]. - Operating cash flow for the year ended December 31, 2025, was $564,270, compared to $347,186 in 2024, indicating a significant increase of 62.5% [22]. - Total expenses for the year ended December 31, 2025, were $4,632,535, an increase of 18.7% from $3,902,181 in 2024 [19]. - Non-GAAP net income for the year ended December 31, 2025, was $386,602, an increase of 20.6% from $320,497 in 2024 [24]. - Adjusted EBITDA for the year ended December 31, 2025, reached $602,350, up 22.8% from $490,392 in 2024 [31]. - Adjusted EBT for the year ended December 31, 2025, was $515,860, a 20.5% increase from $427,976 in 2024 [33]. - Segment income for skilled services was $616,397 for the year ended December 31, 2025, compared to $518,463 in 2024, indicating a 18.9% increase [54]. Acquisitions and Operations - The company acquired 17 new operations during the quarter, bringing the total acquisitions in 2025 to 51 [6]. - Ensign's portfolio consists of 378 healthcare operations across 17 states, with 160 real estate assets owned [8]. - The number of facilities increased to 326 in Q4 2025, a growth of 14.0% compared to 286 in Q4 2024 [37]. - The number of facilities at period end rose to 326, representing a 14.0% increase from 286 in 2024 [40]. - The company maintained 48 transitioning facilities with stable revenue performance [40]. Occupancy and Patient Metrics - Same Facilities and Transitioning Facilities occupancy for the year were 82.9% and 84.2%, respectively, and for the quarter were 83.8% and 84.9%, respectively, showing increases over the prior year [2]. - Actual patient days for Q4 2025 totaled 2,869,685, reflecting a 16.2% increase from 2,469,517 in Q4 2024 [37]. - Occupancy percentage for operational beds improved to 83.2% in Q4 2025, up from 80.9% in Q4 2024 [37]. - Actual patient days reached 10,795,373, an increase of 14.5% compared to 9,431,825 in 2024 [40]. - Occupancy percentage for operational beds improved to 82.2%, up 2.1% from 80.5% in 2024 [40]. Revenue Sources - Medicaid revenue for the year ended December 31, 2025, was $2,002,007, representing 39.8% of total revenue, slightly up from 39.7% in 2024 [51]. - Medicare revenue increased to $1,194,554, accounting for 23.7% of total revenue, down from 24.9% in 2024 [51]. - Managed care revenue for the year ended December 31, 2025, was $944,316, representing 18.8% of total revenue, up from 18.6% in 2024 [51]. - Total Medicaid and Medicare revenue combined was $3,497,683, making up 69.5% of total service revenue, down from 70.9% in 2024 [51]. Stock and Dividends - The company reported a strong liquidity position with approximately $503.9 million of cash on hand and $591.6 million of available capacity under its line-of-credit [6]. - The company plans to continue its dividend payments, having increased the dividend for the 23rd consecutive year [10]. - The company incurred $12,924 in stock-based compensation expense for the three months ended December 31, 2025, compared to $9,820 in the same period of 2024 [24]. - Stock-based compensation expense for Q4 2025 was $12,924, compared to $9,820 in Q4 2024, indicating a 31.5% increase [33]. Revenue Rates and Mix - The average daily revenue rate for Medicare increased to $817.48 from $784.12 in 2024 [44]. - The percentage of skilled nursing revenue from Medicare rose to 21.4% from 20.3% in 2024 [46]. - Skilled nursing revenue mix showed an increase in Medicare from 20.7% in 2024 to 21.4% in 2025 for same facilities [47]. - The percentage of skilled nursing days covered by Medicaid was 57.8% in 2025, slightly down from 58.4% in 2024 [47]. - Recently acquired facilities generated skilled services revenue of $653,063, a significant increase from $163,826 in 2024 [40]. - Same facility skilled services revenue grew by 6.5% to $3,424,421 from $3,214,896 in 2024 [40]. - Recently acquired facilities generated $221,949 in skilled services revenue in Q4 2025, a significant increase from $74,449 in Q4 2024 [38]. - The skilled mix by nursing revenue for Q4 2025 was 49.2%, up from 47.8% in Q4 2024, showing a 2.9% improvement [37]. - The skilled mix by nursing days improved to 30.7%, up from 29.9% in 2024 [40].